Interleukin-2 (IL-2) Mutein Therapies Market Report Infographic Image

Published : February 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Interleukin-2 (IL-2) Mutein Therapies Market Report 2026

Name: Interleukin-2 (IL-2) Mutein Therapies Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Product Type (Monotherapy, Combination Therapy), By Route Of Administration (Intravenous, Subcutaneous, Other Route Of Administrations), By Application (Cancer, Autoimmune Diseases, Infectious Diseases, Other Applications), By End User (Hospitals, Specialty Clinics, Research Institutes, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Interleukin-2 (IL-2) Mutein Therapies Market Overview

• Interleukin-2 (IL-2) Mutein Therapies market size has reached to $0.73 billion in 2025

• Expected to grow to $1.43 billion in 2030 at a compound annual growth rate (CAGR) of 14.4%

• Growth Driver: The Increasing Demand For Targeted Immunotherapies The Growth Of The Market Due To Advancements In Immune-Based Cancer Treatments

• Market Trend: Focus On Advancing Cytokine-based Immunotherapy Through Selective Regulatory T-cell Activation

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Interleukin-2 (IL-2) Mutein Therapies Market?

Interleukin-2 (IL-2) mutein therapies refer to engineered variants of the natural IL-2 cytokine that have been structurally modified to selectively alter receptor binding and immune cell activation. These therapies are designed to enhance therapeutic efficacy and safety by preferentially stimulating specific immune cell populations, such as regulatory T cells or effector T cells, while reducing toxicity.

The main product types of interleukin-2 (IL-2) mutein therapies include monotherapy and combination therapy. Monotherapy refers to treatments where IL-2 muteins are administered alone to modulate the immune system for therapeutic purposes. These therapies are administered via routes including intravenous, subcutaneous, and other routes of administration. They are applied across areas including cancer, autoimmune diseases, infectious diseases, and other applications, and are used by end users including hospitals, specialty clinics, research institutes, and other end users.

Interleukin-2 (IL-2) Mutein Therapies Market Report bar graph

What Is The Interleukin-2 (IL-2) Mutein Therapies Market Size and Share 2026?

The interleukin-2 (il-2) mutein therapies market size has grown rapidly in recent years. It will grow from $0.73 billion in 2025 to $0.84 billion in 2026 at a compound annual growth rate (CAGR) of 14.1%. The growth in the historic period can be attributed to advancements in cytokine engineering techniques, increasing understanding of immune signaling pathways, early clinical success of modified IL-2 therapies, rising investment in immuno-oncology research, growing prevalence of immune-mediated diseases.

What Is The Interleukin-2 (IL-2) Mutein Therapies Market Growth Forecast?

The interleukin-2 (il-2) mutein therapies market size is expected to see rapid growth in the next few years. It will grow to $1.43 billion in 2030 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to expansion of personalized immunotherapy approaches, increasing clinical trial activity for next-generation cytokines, rising demand for safer immune modulators, growing regulatory support for innovative biologics, increasing partnerships between biotech and pharma companies. Major trends in the forecast period include increasing development of receptor-biased il-2 muteins, rising focus on reduced cytokine toxicity profiles, growing use of combination immunotherapy regimens, expansion of precision immune modulation approaches, enhanced clinical pipeline activity for autoimmune and oncology indications.

Book your 30 minutes free consultation with our research experts

Global Interleukin-2 (IL-2) Mutein Therapies Market Segmentation

1) By Product Type: Monotherapy; Combination Therapy

2) By Route Of Administration: Intravenous; Subcutaneous; Other Route Of Administrations

3) By Application: Cancer; Autoimmune Diseases; Infectious Diseases; Other Applications

4) By End User: Hospitals; Specialty Clinics; Research Institutes; Other End Users

Subsegments:

1) By Monotherapy: Single Agent Interleukin Two Mutein Therapy; Standalone Cytokine Based Immunotherapy; Targeted Immune Modulation Therapy

2) By Combination Therapy: Interleukin Two Mutein With Immune Checkpoint Inhibitors; Interleukin Two Mutein With Chemotherapy; Interleukin Two Mutein With Targeted Biologic Therapies; Interleukin Two Mutein With Cell Based Therapies

What Is The Driver Of The Interleukin-2 (IL-2) Mutein Therapies Market?

The increasing demand for targeted immunotherapies is expected to propel the growth of the interleukin-2 (IL-2) mutein therapies market. Targeted immunotherapies are treatments designed to modulate the immune system to selectively attack cancer cells while minimizing damage to healthy tissues. Demand for these therapies is rising as healthcare providers and researchers seek safer, more effective alternatives to conventional chemotherapy and radiation therapy, which are often associated with significant toxicity and limited specificity. IL-2 mutein therapies support the advancement of targeted immunotherapies by utilizing engineered variants of interleukin-2 that selectively stimulate immune effector cells involved in anti-tumor responses while reducing activation of pathways associated with systemic toxicity. For instance, in April 2025, according to the Cancer Research Institute, a US-based non-profit organization, FDA approvals included 17 new targeted immunotherapy agents in 2024, expanding options for targeted immune-based cancer treatment and increasing the pool of patients who can benefit from such therapies. Therefore, the increasing demand for targeted immunotherapies is driving the growth of the interleukin-2 (IL-2) mutein therapies industry.

Key Players In The Global Interleukin-2 (IL-2) Mutein Therapies Market

Major companies operating in the interleukin-2 (il-2) mutein therapies market are Merck & Co. Inc., Sanofi S.A., Roche Holding AG, Bristol-Myers Squibb, Amgen Inc., Lonza Group AG, Alkermes plc, BioNTech SE, Xencor Inc., Innovent Biologics Inc., Ascendis Pharma A/S, ShanghAI Junshi Biosciences Co. Ltd., Mural Oncology Inc., ProBioGen AG, Werewolf Therapeutics Ltd., Philogen S.p.A., Cue Biopharma Inc., Medicenna Therapeutics Corp., Bright Peak Therapeutics Inc., Iovance Biotherapeutics Inc.

Global Interleukin-2 (IL-2) Mutein Therapies Market Trends and Insights

Major companies operating in the interleukin-2 (IL-2) mutein therapies market are increasingly focusing on technological advancements in cytokine-based immunotherapy, such as selective regulatory T-cell (Treg) activation through engineered IL-2 muteins. Selective regulatory T-cell activation via engineered IL-2 muteins involves the use of genetically modified IL-2 proteins designed to preferentially stimulate Tregs while limiting activation of effector immune cells. For instance, in December 2023, Almirall S.A., a Spain-based pharmaceutical company, initiated the first Phase I clinical study of its engineered IL-2 mutein fusion protein, ALM223, to evaluate safety, pharmacokinetics, immunogenicity, and pharmacodynamics in autoimmune diseases. The candidate features selective Treg activation, a modified Fc fusion to improve molecular stability, and an engineered cytokine backbone to optimize immune modulation. While these technological advances highlight the promise of IL-2 muteins in achieving targeted immunomodulation and broader autoimmune applicability, their clinical efficacy and long-term safety profiles remain to be established through ongoing and future trials.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Interleukin-2 (IL-2) Mutein Therapies Market?

In January 2025, Asher Biotherapeutics Inc., a US-based biotechnology company developing and owning IL-2 mutein therapeutics, entered into a partnership with Amgen Inc. to evaluate etakafusp alfa in combination with IMDELLTRA in a Phase 1b clinical trial for extensive-stage small cell lung cancer (ES-SCLC). Through this partnership, the companies aim to advance the clinical development of etakafusp alfa by assessing its potential to enhance T cell–mediated anti-tumor activity when used alongside IMDELLTRA in patients with ES-SCLC. Amgen Inc. is a US-based biotechnology company that develops and commercializes innovative therapies across oncology and other therapeutic areas.

Regional Insights

North America was the largest region in the interleukin 2 (IL-2) mutein therapies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Interleukin-2 (IL-2) Mutein Therapies Market?

The interleukin-2 (IL-2) mutein therapies market consists of sales of efavaleukin alfa, rezpegaldesleukin, bempegaldesleukin, nemvaleukin alfa.Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Interleukin-2 (IL-2) Mutein Therapies Market Report 2026?

The interleukin-2 (il-2) mutein therapies market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the interleukin-2 (il-2) mutein therapies industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Interleukin-2 (IL-2) Mutein Therapies Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$0.84 billion
Revenue Forecast In 2035	$1.43 billion
Growth Rate	CAGR of 14.1% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Product Type, Route Of Administration, Application, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Merck & Co. Inc., Sanofi S.A., Roche Holding AG, Bristol-Myers Squibb, Amgen Inc., Lonza Group AG, Alkermes plc, BioNTech SE, Xencor Inc., Innovent Biologics Inc., Ascendis Pharma A/S, ShanghAI Junshi Biosciences Co. Ltd., Mural Oncology Inc., ProBioGen AG, Werewolf Therapeutics Ltd., Philogen S.p.A., Cue Biopharma Inc., Medicenna Therapeutics Corp., Bright Peak Therapeutics Inc., Iovance Biotherapeutics Inc.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Interleukin-2 (IL-2) Mutein Therapies Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Interleukin-2 (IL-2) Mutein Therapies Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Interleukin-2 (IL-2) Mutein Therapies Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Interleukin-2 (IL-2) Mutein Therapies Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Increasing Development Of Receptor-Biased Il-2 Muteins

4.2.2 Rising Focus On Reduced Cytokine Toxicity Profiles

4.2.3 Growing Use Of Combination Immunotherapy Regimens

4.2.4 Expansion Of Precision Immune Modulation Approaches

4.2.5 Enhanced Clinical Pipeline Activity For Autoimmune And Oncology Indications

5. Interleukin-2 (IL-2) Mutein Therapies Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Research Institutes

5.4 Pharmaceutical Companies

5.5 Biotechnology Companies

6. Interleukin-2 (IL-2) Mutein Therapies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Interleukin-2 (IL-2) Mutein Therapies Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Interleukin-2 (IL-2) Mutein Therapies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Interleukin-2 (IL-2) Mutein Therapies Market Size, Comparisons And Growth Rate Analysis

7.3. Global Interleukin-2 (IL-2) Mutein Therapies Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Interleukin-2 (IL-2) Mutein Therapies Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Interleukin-2 (IL-2) Mutein Therapies Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Interleukin-2 (IL-2) Mutein Therapies Market Segmentation

9.1. Global Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Monotherapy, Combination Therapy

9.2. Global Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Intravenous, Subcutaneous, Other Route Of Administrations

9.3. Global Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cancer, Autoimmune Diseases, Infectious Diseases, Other Applications

9.4. Global Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Specialty Clinics, Research Institutes, Other End Users

9.5. Global Interleukin-2 (IL-2) Mutein Therapies Market, Sub-Segmentation Of Monotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Single Agent Interleukin Two Mutein Therapy, Standalone Cytokine Based Immunotherapy, Targeted Immune Modulation Therapy

9.6. Global Interleukin-2 (IL-2) Mutein Therapies Market, Sub-Segmentation Of Combination Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Interleukin Two Mutein With Immune Checkpoint Inhibitors, Interleukin Two Mutein With Chemotherapy, Interleukin Two Mutein With Targeted Biologic Therapies, Interleukin Two Mutein With Cell Based Therapies

10. Interleukin-2 (IL-2) Mutein Therapies Market Regional And Country Analysis

10.1. Global Interleukin-2 (IL-2) Mutein Therapies Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Interleukin-2 (IL-2) Mutein Therapies Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Interleukin-2 (IL-2) Mutein Therapies Market

11.1. Asia-Pacific Interleukin-2 (IL-2) Mutein Therapies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Interleukin-2 (IL-2) Mutein Therapies Market

12.1. China Interleukin-2 (IL-2) Mutein Therapies Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Interleukin-2 (IL-2) Mutein Therapies Market

13.1. India Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Interleukin-2 (IL-2) Mutein Therapies Market

14.1. Japan Interleukin-2 (IL-2) Mutein Therapies Market Overview

14.2. Japan Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Interleukin-2 (IL-2) Mutein Therapies Market

15.1. Australia Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Interleukin-2 (IL-2) Mutein Therapies Market

16.1. Indonesia Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Interleukin-2 (IL-2) Mutein Therapies Market

17.1. South Korea Interleukin-2 (IL-2) Mutein Therapies Market Overview

17.2. South Korea Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Interleukin-2 (IL-2) Mutein Therapies Market

18.1. Taiwan Interleukin-2 (IL-2) Mutein Therapies Market Overview

18.2. Taiwan Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Interleukin-2 (IL-2) Mutein Therapies Market

19.1. South East Asia Interleukin-2 (IL-2) Mutein Therapies Market Overview

19.2. South East Asia Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Interleukin-2 (IL-2) Mutein Therapies Market

20.1. Western Europe Interleukin-2 (IL-2) Mutein Therapies Market Overview

20.2. Western Europe Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Interleukin-2 (IL-2) Mutein Therapies Market

21.1. UK Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Interleukin-2 (IL-2) Mutein Therapies Market

22.1. Germany Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Interleukin-2 (IL-2) Mutein Therapies Market

23.1. France Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Interleukin-2 (IL-2) Mutein Therapies Market

24.1. Italy Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Interleukin-2 (IL-2) Mutein Therapies Market

25.1. Spain Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Interleukin-2 (IL-2) Mutein Therapies Market

26.1. Eastern Europe Interleukin-2 (IL-2) Mutein Therapies Market Overview

26.2. Eastern Europe Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Interleukin-2 (IL-2) Mutein Therapies Market

27.1. Russia Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Interleukin-2 (IL-2) Mutein Therapies Market

28.1. North America Interleukin-2 (IL-2) Mutein Therapies Market Overview

28.2. North America Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Interleukin-2 (IL-2) Mutein Therapies Market

29.1. USA Interleukin-2 (IL-2) Mutein Therapies Market Overview

29.2. USA Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Interleukin-2 (IL-2) Mutein Therapies Market

30.1. Canada Interleukin-2 (IL-2) Mutein Therapies Market Overview

30.2. Canada Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Interleukin-2 (IL-2) Mutein Therapies Market

31.1. South America Interleukin-2 (IL-2) Mutein Therapies Market Overview

31.2. South America Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Interleukin-2 (IL-2) Mutein Therapies Market

32.1. Brazil Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Interleukin-2 (IL-2) Mutein Therapies Market

33.1. Middle East Interleukin-2 (IL-2) Mutein Therapies Market Overview

33.2. Middle East Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Interleukin-2 (IL-2) Mutein Therapies Market

34.1. Africa Interleukin-2 (IL-2) Mutein Therapies Market Overview

34.2. Africa Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Interleukin-2 (IL-2) Mutein Therapies Market Regulatory and Investment Landscape

36. Interleukin-2 (IL-2) Mutein Therapies Market Competitive Landscape And Company Profiles

36.1. Interleukin-2 (IL-2) Mutein Therapies Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Interleukin-2 (IL-2) Mutein Therapies Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Interleukin-2 (IL-2) Mutein Therapies Market Company Profiles

36.3.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Bristol-Myers Squibb Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Interleukin-2 (IL-2) Mutein Therapies Market Other Major And Innovative Companies

Lonza Group AG, Alkermes plc, BioNTech SE, Xencor Inc., Innovent Biologics Inc., Ascendis Pharma A/S, Shanghai Junshi Biosciences Co. Ltd., Mural Oncology Inc., ProBioGen AG, Werewolf Therapeutics Ltd., Philogen S.p.A., Cue Biopharma Inc., Medicenna Therapeutics Corp., Bright Peak Therapeutics Inc., Iovance Biotherapeutics Inc.

38. Global Interleukin-2 (IL-2) Mutein Therapies Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Interleukin-2 (IL-2) Mutein Therapies Market

41. Interleukin-2 (IL-2) Mutein Therapies Market High Potential Countries, Segments and Strategies

41.1 Interleukin-2 (IL-2) Mutein Therapies Market In 2030 - Countries Offering Most New Opportunities

41.2 Interleukin-2 (IL-2) Mutein Therapies Market In 2030 - Segments Offering Most New Opportunities

41.3 Interleukin-2 (IL-2) Mutein Therapies Market In 2030 - Growth Strategies

41.3.1 Market Trend Based Strategies

41.3.2 Competitor Strategies

42. Appendix

42.1. Abbreviations

42.2. Currencies

42.3. Historic And Forecast Inflation Rates

42.4. Research Inquiries

42.5. The Business Research Company

42.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Interleukin-2 (IL-2) Mutein Therapies Market, Overview Of Key Products - Product Examples

Table 2: Global Interleukin-2 (IL-2) Mutein Therapies Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Interleukin-2 (IL-2) Mutein Therapies Market, Supply Chain Analysis

Table 4: Global Interleukin-2 (IL-2) Mutein Therapies Market, Major Raw Material Providers

Table 5: Global Interleukin-2 (IL-2) Mutein Therapies Market, Major Resource Providers

Table 6: Global Interleukin-2 (IL-2) Mutein Therapies Market, Major Manufacturers (Suppliers)

Table 7: Global Interleukin-2 (IL-2) Mutein Therapies Market, Major Distributors And Channel Partners

Table 8: Global Interleukin-2 (IL-2) Mutein Therapies Market, Key Technologies & Future Trends

Table 9: Global Interleukin-2 (IL-2) Mutein Therapies Market, Major Trends

Table 10: Global Interleukin-2 (IL-2) Mutein Therapies Market, Major End Users

Table 11: Global Interleukin-2 (IL-2) Mutein Therapies Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Interleukin-2 (IL-2) Mutein Therapies Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Interleukin-2 (IL-2) Mutein Therapies Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Interleukin-2 (IL-2) Mutein Therapies Market - TAM, US$ Billion, 2025

Table 15: Global Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Interleukin-2 (IL-2) Mutein Therapies Market, Sub-Segmentation Of Monotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Interleukin-2 (IL-2) Mutein Therapies Market, Sub-Segmentation Of Combination Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Interleukin-2 (IL-2) Mutein Therapies Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Interleukin-2 (IL-2) Mutein Therapies Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Indonesia, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: South Korea, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Taiwan, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South East Asia, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Western Europe, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: UK, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Germany, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: France, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Italy, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Spain, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Eastern Europe, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Russia, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: North America, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: USA, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: Canada, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: South America, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Brazil, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Middle East, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Africa, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Global Interleukin-2 (IL-2) Mutein Therapies Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 96: Global Interleukin-2 (IL-2) Mutein Therapies Market - Company Scoring Matrix

Table 97: Upcoming Startups

Table 98: Merck & Co. Inc. Financial Performance

Table 99: Sanofi S.A. Financial Performance

Table 100: Roche Holding AG Financial Performance

Table 101: Bristol-Myers Squibb Financial Performance

Table 102: Amgen Inc. Financial Performance

Table 103: Global Interleukin-2 (IL-2) Mutein Therapies Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Interleukin-2 (IL-2) Mutein Therapies Market, Competitive Dashboard

Table 105: Global Interleukin-2 (IL-2) Mutein Therapies Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Interleukin-2 (IL-2) Mutein Therapies Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030

Table 107: Global, Interleukin-2 (IL-2) Mutein Therapies Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Table 108: Global, Interleukin-2 (IL-2) Mutein Therapies Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

Figure 1: Global Interleukin-2 (IL-2) Mutein Therapies Market, Overview Of Key Products - Product Examples

Figure 2: Global Interleukin-2 (IL-2) Mutein Therapies Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Interleukin-2 (IL-2) Mutein Therapies Market, Supply Chain Analysis

Figure 4: Global Interleukin-2 (IL-2) Mutein Therapies Market, Major Raw Material Providers

Figure 5: Global Interleukin-2 (IL-2) Mutein Therapies Market, Major Resource Providers

Figure 6: Global Interleukin-2 (IL-2) Mutein Therapies Market, Major Manufacturers (Suppliers)

Figure 7: Global Interleukin-2 (IL-2) Mutein Therapies Market, Major Distributors And Channel Partners

Figure 8: Global Interleukin-2 (IL-2) Mutein Therapies Market, Key Technologies & Future Trends

Figure 9: Global Interleukin-2 (IL-2) Mutein Therapies Market, Major Trends

Figure 10: Global Interleukin-2 (IL-2) Mutein Therapies Market, Major End Users

Figure 11: Global Interleukin-2 (IL-2) Mutein Therapies Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Interleukin-2 (IL-2) Mutein Therapies Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Interleukin-2 (IL-2) Mutein Therapies Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Interleukin-2 (IL-2) Mutein Therapies Market - TAM, US$ Billion, 2025

Figure 15: Global Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Interleukin-2 (IL-2) Mutein Therapies Market, Sub-Segmentation Of Monotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Interleukin-2 (IL-2) Mutein Therapies Market, Sub-Segmentation Of Combination Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Interleukin-2 (IL-2) Mutein Therapies Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Interleukin-2 (IL-2) Mutein Therapies Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Indonesia, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: South Korea, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Taiwan, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South East Asia, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Western Europe, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: UK, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Germany, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: France, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Italy, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Spain, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Eastern Europe, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Russia, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: North America, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: USA, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: Canada, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: South America, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Brazil, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Middle East, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Africa, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Interleukin-2 (IL-2) Mutein Therapies Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Global Interleukin-2 (IL-2) Mutein Therapies Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 96: Global Interleukin-2 (IL-2) Mutein Therapies Market - Company Scoring Matrix

Figure 97: Upcoming Startups

Figure 98: Merck & Co. Inc. Financial Performance

Figure 99: Sanofi S.A. Financial Performance

Figure 100: Roche Holding AG Financial Performance

Figure 101: Bristol-Myers Squibb Financial Performance

Figure 102: Amgen Inc. Financial Performance

Figure 103: Global Interleukin-2 (IL-2) Mutein Therapies Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Interleukin-2 (IL-2) Mutein Therapies Market, Competitive Dashboard

Figure 105: Global Interleukin-2 (IL-2) Mutein Therapies Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Interleukin-2 (IL-2) Mutein Therapies Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030

Figure 107: Global, Interleukin-2 (IL-2) Mutein Therapies Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Figure 108: Global, Interleukin-2 (IL-2) Mutein Therapies Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Affiliate Software Market Report 2026 - Global Outlook – By Type (On-Premise, Cloud-Based), By Application (Small And Medium Enterprises, Large Enterprises), By End-User (Retailers, Publishers, Advertisers) – Market Size...

Teleradiology Market Report 2026 - Global Outlook – By Modality (X-Ray, Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Ultrasound Systems), By Technology (Web Based, Cloud Based), By Component (Hardware...

Servers Technology Market Report 2026 - Global Outlook – By Product (Blade, Micro, Open Compute Project, Rack, Tower), By Enterprise Size (Micro, Small, Medium, Large), By End User (Banking, Financial Services And Insura...

Foreign Body Removal Market Report 2026 - Global Outlook – By Device Type (Forceps, Retrieval Baskets, Balloon Catheter, Other Device Types), By Application (Stomach, Gut, Mouth, Ear, Nose, Other Applications), By End Us...

Employee Monitoring Software Market Report 2026 - Global Outlook – By Type (Premises Employee Monitoring, Remote Employee Monitoring), By Deployment Mode (Hybrid, Cloud Based, On-Premises), By Features (Productivity Moni...

Frequently Asked Questions

How big is the Interleukin-2 (IL-2) Mutein Therapies Market?

The Interleukin-2 (IL-2) Mutein Therapies market was valued at $0.73 billion in 2025, increased to $0.84 billion in 2026, and is projected to reach $1.43 billion by 2030.

What is the Interleukin-2 (IL-2) Mutein Therapies market growth?

The global Interleukin-2 (IL-2) Mutein Therapies market is expected to grow at a CAGR of 14.4% from 2026 to 2035 to reach $1.43 billion by 2035.

Who are the key players in Interleukin-2 (IL-2) Mutein Therapies market?

Some Key Players in the Interleukin-2 (IL-2) Mutein Therapies market Include, Merck & Co. Inc., Sanofi S.A., Roche Holding AG, Bristol-Myers Squibb, Amgen Inc., Lonza Group AG, Alkermes plc, BioNTech SE, Xencor Inc., Innovent Biologics Inc., Ascendis Pharma A/S, ShanghAI Junshi Biosciences Co. Ltd., Mural Oncology Inc., ProBioGen AG, Werewolf Therapeutics Ltd., Philogen S.p.A., Cue Biopharma Inc., Medicenna Therapeutics Corp., Bright Peak Therapeutics Inc., Iovance Biotherapeutics Inc. .

What is the anticipated growth trend for the Interleukin-2 (IL-2) Mutein Therapies market?

Major trend in this market includes: Focus On Advancing Cytokine-based Immunotherapy Through Selective Regulatory T-cell Activation. For further insights on this market. request a sample here

Which region has the most growth potential in the Interleukin-2 (IL-2) Mutein Therapies market?

North America was the largest region in the interleukin 2 (IL-2) mutein therapies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the interleukin-2 (il-2) mutein therapies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.